Urogenital Neoplasms  >>  epirubicin  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NMIBCIVT, NCT02214602: Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer

Completed
4
240
RoW
Epirubicin, Intravesical chemotherapy, Doxorubicin
Mansoura University
Carcinoma of Urinary Bladder, Superficial
04/17
05/17

Download Options